Former U.S. Sen. Norm Coleman, left, walks with Pete Hegseth, President-elect Donald Trump's nominee to be defense secretary, to meet with senators at the Capitol in Washington, Tuesday ...

Deborah Morrow sent FOX 8 video from inside her home as the plant came down. According to the City of Avon Lake, The Avon Lake Environmental Redevelopment Group, or ALERG, will continue to monitor ...

The resignation was stated not to be triggered by any disagreement with Tenaya concerning the company’s financials, operations, policies, or practices. 10 Stocks to Sell NOW! 3 Stocks to DOUBLE ...

We may earn commission if you buy from a link. Why Trust Us? Scientists thought that Lake Enigma in Antarctica was frozen from top to bottom. But, in 2019, they discovered that water existed 11 ...

Morgan Stanley analyst Michael Ulz maintained a Buy rating on Tenaya Therapeutics (TNYA – Research Report) yesterday and set a price target of $15.00. Discover top-rated stocks from highly ...

Tenaya’s share slump following the TN-201 data drop could be due to its “significantly lower” level of RNA expression in the Phase Ib/II trial than in preclinical models, according to William Blair ...

Leerink lowered the firm’s price target on Tenaya Therapeutics (TNYA) to $6 from $8 and keeps an Outperform rating on the shares after the company announced initial Phase 1b/2 MyPEAK-1 data for ...

Tenaya Therapeutics (TNYA) reported encouraging early data from the first cohort of patients in the MyPEAK-1 clinical trial of TN-201 gene therapy. TN-201 is being developed for the potential ...

SOUTH SAN FRANCISCO - Tenaya Therapeutics, Inc. (NASDAQ ... with measurable transgene RNA expression and a 3% increase in MyBP-C protein levels from weeks 8 to 52 in one patient. This suggests that ...

SOUTH SAN FRANCISCO - Tenaya Therapeutics ... RNA expression and a 3% increase in MyBP-C protein levels from weeks 8 to 52 in one patient. This suggests that the therapy is being transcribed ...